Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01558648 · ClinicalTrials.gov registry record

Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
257
Enrollment target

NCT01558648: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01558648 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 257 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01558648 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
257 participants
Enrollment target

Study Summary

The goal of this study is to evaluate how surgery for esophageal cancer affects the patient's quality of life over time. The investigators hope this study will provide important information that can be used to improve the quality of life of patients with esophageal cancer. This study will also look at how standard tests and information collected from the patients difficulty swallowing can predict the extent of their esophageal cancer before surgery.

Interventions

  • BEHAVIORAL Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log

Trial Details

FieldValue
Enrollment Target 257 participants
Start Date 2012-03-14
Est. Completion 2021-08-04

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01558648

The ClinicalTrials.gov registry entry for NCT01558648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log is the first listed.

NCT01558648 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01558648 about?

NCT01558648 is a clinical study titled "Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer". The goal of this study is to evaluate how surgery for esophageal cancer affects the patient's quality of life over time. The investigators hope this study will provide important information that can be used to improve the quality of life of patients with esophageal cancer. This study will also look ...

What is the current status of trial NCT01558648?

This trial is currently completed. The enrollment target is 257 participants. The study started on 2012-03-14. Estimated completion is 2021-08-04.

What interventions are being tested in trial NCT01558648?

The interventions under investigation include: Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log (BEHAVIORAL).

Who is sponsoring clinical trial NCT01558648?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.